Detalhe da pesquisa
1.
Hsa_circ_0003945 promotes progression of hepatocellular carcinoma by mediating miR-34c-5p/LGR4/ß-catenin axis activity.
J Cell Mol Med
; 26(8): 2218-2229, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35170199
2.
Exosomal microRNAs in the DLK1-DIO3 imprinted region derived from cancer-associated fibroblasts promote progression of hepatocellular carcinoma by targeting hedgehog interacting protein.
BMC Gastroenterol
; 22(1): 505, 2022 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482325
3.
High serum soluble CD155 level predicts poor prognosis and correlates with an immunosuppressive tumor microenvironment in hepatocellular carcinoma.
J Clin Lab Anal
; 36(3): e24259, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35089611
4.
Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target.
BMC Cancer
; 19(1): 760, 2019 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31370822
5.
Application of Serum Annexin A3 in Diagnosis, Outcome Prediction and Therapeutic Response Evaluation for Patients with Hepatocellular Carcinoma.
Ann Surg Oncol
; 25(6): 1686-1694, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29626309
6.
Dynamic change of the systemic immune inflammation index predicts the prognosis of patients with hepatocellular carcinoma after curative resection.
Clin Chem Lab Med
; 54(12): 1963-1969, 2016 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27010778
7.
Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity.
Curr Stem Cell Res Ther
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38561604
8.
Stigmasterol: Remodeling gut microbiota and suppressing tumor growth through Treg and CD8+ T cells in hepatocellular carcinoma.
Phytomedicine
; 129: 155225, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38678948
9.
[Ecological Toxic Effect of Perfluorinated Compounds on Fish Based on Meta-analysis].
Huan Jing Ke Xue
; 44(9): 5231-5241, 2023 Sep 08.
Artigo
em Zh
| MEDLINE | ID: mdl-37699841
10.
Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma.
Front Immunol
; 13: 831101, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35371079
11.
CD155/SRC complex promotes hepatocellular carcinoma progression via inhibiting the p38 MAPK signalling pathway and correlates with poor prognosis.
Clin Transl Med
; 12(4): e794, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384345
12.
BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity.
Cell Death Dis
; 11(10): 895, 2020 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33093445
13.
Elevated soluble programmed death-ligand 1 levels indicate immunosuppression and poor prognosis in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization.
Clin Chim Acta
; 511: 67-74, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32979338
14.
CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110ß and predicts poor prognosis.
J Hematol Oncol
; 12(1): 37, 2019 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30971294
15.
Significance of PIVKA-II levels for predicting microvascular invasion and tumor cell proliferation in Chinese patients with hepatitis B virus-associated hepatocellular carcinoma.
Oncol Lett
; 15(6): 8396-8404, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29805574
16.
[Alteration of Th17 cells, immunoglobins and complements levels in peripheral blood of patients with refractory recurrent aphthous ulcer].
Shanghai Kou Qiang Yi Xue
; 26(5): 521-525, 2017 Oct.
Artigo
em Zh
| MEDLINE | ID: mdl-29308514
17.
Serum IgG4:IgG Ratio Predicts Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection.
J Cancer
; 8(8): 1338-1346, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28638447
18.
Application of the albumin-bilirubin grade for predicting prognosis after curative resection of patients with early-stage hepatocellular carcinoma.
Clin Chim Acta
; 462: 15-22, 2016 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27520748
19.
MiR-1297 regulates the growth, migration and invasion of colorectal cancer cells by targeting cyclo-oxygenase-2.
Asian Pac J Cancer Prev
; 15(21): 9185-90, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25422199
20.
Elevated PIVKA-II is associated with early recurrence and poor prognosis in BCLC 0-A hepatocellular carcinomas.
Asian Pac J Cancer Prev
; 15(16): 6673-8, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25169507